Abstract
Lutzomyia evansi is a phlebotomine insect endemic to Colombia’s Caribbean coast and is considered the main vector of visceral and cutaneous leishmaniasis in the region. Specific studies of the direct effects generated by bacteria in the digestive tract of the insect vectors, under Leishmania infantum using in vitro models, represent a novel alternative as a control strategy for the transmission of leishmaniasis and also provide the opportunity to detect natural products or antimicrobial peptides with different biological activities. In this study, we evaluate the leishmanicidal and antimicrobial activities of Pantoea ananatis, Ochrobactrum anthropi and Enterobacter cloacae, isolated from the digestive tract of Lutzomyia evansi and the susceptibility of these bacteria to commonly used antibiotics. The antagonistic effect of Pantoea ananatis, Ochrobactrum anthropi and Enterobacter cloacae was evaluated against six species of human pathogenic bacteria and against stationary (Metacyclic-like) and exponential promastigotes (Procyclic-like) of Leishmania infantum (BCN-GFP strain) by co-culture assays for 24 hours. The activity of the bacterial isolates on Leishmania infantum promastigotes was quantified by flow cytometry. The susceptibility of the bacterial strains to clinically used antibiotics was analyzed by antibiogram. The highest percentage of inhibition was observed against exponential promastigotes with bacterial concentrations of 108 CFU/ml of Enterobacter cloacae (77.29% ± 0.6%) and Pantoea ananatis (70.17% ± 1.1%). The extracts produced by three bacterial isolates showed similar biological activity (13 mm - 22 mm inhibition halos) against all tested bacteria; however, significant differences were observed with respect to gram-positive bacteria (P Bacillus cereus. Ochrobactrum anthropi was the isolate with the highest number of antibiotic resistance patterns while Pantoea ananatis and Enterobacter cloacae showed greater susceptibility to the evaluated antibiotics. The growth inhibitory activity of exponential Leishmania infantum promastigotes shown by extracts of Enterobacter cloacae and Pantoea ananantis suggests that the presence of these bacteria in the vector intestine may affect the parasite development to metacyclic stages, infective to human hosts. This in turn confers said bacteria, a potential in controlling the transmission of Leishmania spp. that deserves to be studied in depth.
Highlights
Leishmaniasis remains as a public health problem worldwide due to its morbidity and geographical distribution [1]
We evaluate the leishmanicidal and antimicrobial activities of Pantoea ananatis, Ochrobactrum anthropi and Enterobacter cloacae, isolated from the digestive tract of Lutzomyia evansi and the susceptibility of these bacteria to commonly used antibiotics
The antagonistic effect of Pantoea ananatis, Ochrobactrum anthropi and Enterobacter cloacae was evaluated against six species of human pathogenic bacteria and against stationary (Metacyclic-like) and exponential promastigotes (Procyclic-like) of Leishmania infantum (BCN-GFP strain) by co-culture assays for 24 hours
Summary
Leishmaniasis remains as a public health problem worldwide due to its morbidity and geographical distribution [1]. The VL presents difficulties associated with treatment, diagnostic tests and surveillance and control strategies of insect vectors [5]. This problem is attributed mainly to the emergence of drug-resistant strains of the L. infantum parasite, as well as the ubiquity and adaptability of vector insects, Lu. longipalpis, and Lu. evansi, and the existence of different eco-epidemiological settings where transmission can occur [6] [7]. It is necessary to explore alternatives aimed at interrupting the transmission of the infection and thereby reduce the impact of leishmaniasis in public health [8]. An alternative option to the chemical control of vectors or to the synthetic generation of vaccines and treatments is to understand the “intestinal microbiota” of sandflies vectors [9] [10]
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
